secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORAMED PHARMACEUTICALS INC. (ORMP)
CIK:        0001176309
Form:       8-K
Filed at:   2024-06-26T23:59:59+00:00
Accession:  0001213900-24-055950
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Oramed authorizes up to $20M stock buyback program over 12 months
-----------------------------------------------------------------

- Board authorized up to $20M in common stock repurchases, expiring in 12 months.
- Repurchases may be on open market or private transactions under Rule 10b-18.
- Program does not obligate purchase; can be terminated or modified by Board at any time.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1176309/000121390024055950/0001213900-24-055950-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1176309/000121390024055950/ea0208443-8k_oramed.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-055950

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer